Trial intelligence / Profile preview

Effect of Macrodex versus lactated Ringer on coagulation in major surgery

2012-005040-20Phase 4Completed

Sponsor
Rigshospitalet
Start
Jan 2013
Modality
Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of dextran in bladder cancer (2 arms), sponsored by Rigshospitalet. Primary endpoint: Coagulation competence. Started Jan 2013; status: completed.

02

Drugs

dextran
03

Conditions

bladder cancer

Beyond the preview

Go deeper on 2012-005040-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005040-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call